Apolipoprotein C-II Is a Potential Serum Biomarker as a Prognostic Factor of Locally Advanced Cervical Cancer After Chemoradiation Therapy-Reference-Cited by-同舟云学术

Apolipoprotein C-II Is a Potential Serum Biomarker as a Prognostic Factor of Locally Advanced Cervical Cancer After Chemoradiation Therapy

Published:2013-12 Issue:5 Volume:87 Page:1155-1161
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Harima Yoko,Ikeda Koshi,Utsunomiya Keita,Komemushi Atsushi,Kanno Shohei,Shiga Toshiko,Tanigawa Noboru

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference23 articles.

1. Worldwide burden of cervical cancer in 2008;Arbyn;Ann Oncol,2011

2. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: Individual patient data meta-analysis;Cochrane Database Syst Rev,2010

3. Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: A systematic review;Noordhuis;Int J Radiat Oncol Biol Phys,2011

4. Identification of genes associated with progression and metastasis of advanced cervical cancers after radiotherapy by cDNA microarray analysis;Harima;Int J Radiat Oncol Biol Phys,2009

5. Characterization of the human blood plasma proteome;Shen;Proteomics,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Proteomic Signatures in Cervical Cancer: Current Status and Future Directions;Cancers;2024-04-24

2. The Role of Apolipoproteins in the Commonest Cancers: A Review;Cancers;2023-11-24

3. Apolipoproteins: New players in cancers;Frontiers in Pharmacology;2022-11-25

4. Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study;PLOS ONE;2021-11-02

5. Apolipoprotein C‐II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway;Clinical and Translational Medicine;2021-08